chrisvoncsefalvay/vaers-outcomes huggingface dataset:
rash-all over, shortness of breath, fever 103, body aches, severe injection site soreness
Menveo liquid component only; patient received only liquid component; This case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 11-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA729A, expiry date 30th September 2023) for prophylaxis.   On 23rd August 2022, the patient received Menveo. On 23rd August 2022, unknown after receiving Menveo, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 24-AUG-2022 Reporter's Comments: The nurse reported that a patient received only the liquid component of Menveo on 23rd Aug 2022.  The reporter consent to follow up. Additional Supportive Information: The nurse reported that a patient received only the liquid component of the Menveo vaccine, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
Injection site: sharp pain, swelling, stiffness Left arm: (injection site symptoms), shooting muscle pain from fingertips to occipital, very limited mobility in arm, wrist, shoulder, neck, sleeplessness, fatigue, dizziness,  Overall joint, muscle, tissue related pain due to previously identified chronic diagnose are exacerbated/intensified to the point of interference with expected daily activity
Headache, Arthralgia, FATIGUE, PAIN/SWELLING INJ SITE Narrative:  Other Relevant History:
Within 24 hours, left arm was red from shoulder to top of elbow, swollen, and very hot to the touch for 9 days. Patient was put on Augmentin for 14 days. Arm still slightly red; now gone.
Anxiety; Pain in arm; Temperature that lasted for four days; Headaches that lasted for several days; tired; itching that started in the palm of right hand and spread to the palm of the left hand; pins and needles and numbness in both palms of their hands; hands feel hot and inflamed; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Anxiety), PAIN IN EXTREMITY (Pain in arm), PYREXIA (Temperature that lasted for four days), HEADACHE (Headaches that lasted for several days) and FATIGUE (tired) in a 63-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Rheumatoid arthritis and Type 2 diabetes mellitus. Concomitant products included TOFACITINIB CITRATE (XELJANZ), MELATONIN, DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) and PREDNISONE for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ANXIETY (Anxiety), PAIN IN EXTREMITY (Pain in arm), PYREXIA (Temperature that lasted for four days), HEADACHE (Headaches that lasted for several days), FATIGUE (tired), PRURITUS (itching that started in the palm of right hand and spread to the palm of the left hand), HYPOAESTHESIA (pins and needles and numbness in both palms of their hands) and FEELING HOT (hands feel hot and inflamed). At the time of the report, ANXIETY (Anxiety), PAIN IN EXTREMITY (Pain in arm), HEADACHE (Headaches that lasted for several days), FATIGUE (tired), PRURITUS (itching that started in the palm of right hand and spread to the palm of the left hand), HYPOAESTHESIA (pins and needles and numbness in both palms of their hands) and FEELING HOT (hands feel hot and inflamed) outcome was unknown and PYREXIA (Temperature that lasted for four days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was reported.
PATIENT GIVEN MODERNA VACCINE WHEN UNDER AGE OF 18 - NO REACTION AS OF 3 HOURS POST VACCINATION
Treatment of COVID-19/Pfizer / BioNTech(30Sep2021); Treatment of COVID-19/Pfizer / BioNTech(30Sep2021); This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 30Sep2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 33 years for covid-19 immunization; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history included: "Ehlers Danlos Syndrome" (unspecified if ongoing); "asthma" (unspecified if ongoing); "known allergies: Mango" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19/Pfizer / BioNTech(30Sep2021)". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: Indication: Covid-19 treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical Course: Adverse event: Recurrence of COVID symptoms on day 10 that lasted for an additional 8 days. New symptoms developed that I did not experience during the initial cycle of Paxlovid, including severe sinus congestion, eye watering and swelling, and loss of taste and smell. If vaccine received: Yes, Other medication in 2weeks: No.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Employee received anthrax vaccine on 04/10/2002. On 04/18/2002 at injection site she developed red and indurated (7cm), warm to touch and mild pain.
Lips swelled 20-25 minutes after receiving the shot.  Lasted 3 hours.
some people had rashes that looked like mosquito bites after receiving their Moderna vaccines/pastor's daughter; This spontaneous case was reported by a consumer and describes the occurrence of RASH (some people had rashes that looked like mosquito bites after receiving their Moderna vaccines/pastor's daughter) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (some people had rashes that looked like mosquito bites after receiving their Moderna vaccines/pastor's daughter). At the time of the report, RASH (some people had rashes that looked like mosquito bites after receiving their Moderna vaccines/pastor's daughter) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided by the reporter.  No treatment information was provided by the reporter.   This case was linked to MOD21-115324, MOD-2021-236284, MOD-2021-247899, MOD-2021-247899, MOD-2021-236284 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Follow-up received included no new information
Information has been received from a nurse practitioner concerning a female nurse who on 08 Nov 2006 was splashed in the eye with a dose of varicella zoster virus vaccine live. The patient experienced hemorrhaging in the eye immediately following exposure to the vaccine. It was also reported that she was experiencing redness in her eye. The patient went to an eye doctor who said that the  incident should resolve without complication. As of 09 Nov 2006, no other symptoms were reported since the incident. A product quality complaint was not involved. Additional information has been requested.
The drug store where I went to get the Moderna vaccine stated they didn't have Moderna and we were getting Pfizer,  and the drug store does not know what vaccine I received and they stated that it was alright to take a different vaccine for the 2nd dose. There were about 6 others at the site that was vaccinated that day and they need to be notified as well.  The regional manager stated that they can back up the Pfizer with Moderna, store does not know which vaccine they gave me and I'm scheduled for my 2nd dose tomorrow.  Was advised to go to the doctor to get a blood test to see which vaccine I received.
Eye infection; This spontaneous case was reported by a consumer and describes the occurrence of EYE INFECTION (Eye infection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EYE INFECTION (Eye infection). The patient was treated with CEFALEXIN (KEFLEX [CEFALEXIN]) for Eye infection, at an unspecified dose and frequency and DOXYCYCLINE for Eye infection, at an unspecified dose and frequency. At the time of the report, EYE INFECTION (Eye infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported The patient was scheduled to get 2nd dose of Moderna Vaccine on Friday, 12 Feb 2021.
Per patient report, he states he received the first dose of the COVID19 vaccine on 1/23/21. He began noticing sporadic arm twitching , jerking, and paralysis on 1/31/21. He went to urgent care who told him the vaccine may have hit a nerve and to come to ED if not improving. He states the symptoms worsened so he came to the ED for a full workup.
Fever as high as 102.4 for 36 hours  Chills 12 hours Headache 36 hours Nausea 12 hours
Fever 102.3, muscle pains, and blurred vision for 3 days, which has not been reported among side effects of this vaccine by CDC
Fatigue since day given vaccine. Cheek swelling, headache and dizziness/vertigo for one day (5/18).
Information has been received from a pharmacist concerning an 88 year old female with hypertension who on 12-JAN-2007 was vaccinated with ZOSTAVAX. Concomitant therapy included VALTREX and cardiovascular medications. The pharmacist reported that approximately on 07-JUL-2008, the patient experienced shingles. At the time of the report, the patient had not recovered. The patient sought unspecified medical attention.
Bruise appeared 2 days after with some pain x2 weeks. No fever. Bruise improving but still present. No pain or others symptoms.
Vaccinated with Moderna vaccines for Covid in April and May 2021.  Developed symptoms on 11/27 - headache, nasal congestion, myalgia, sore throat, loss of taste and smell.  Tested PCR + for Covid 12/3/2021.  Breakthrough Covid case.
Should pain after vaccine from Pfizer; This is a spontaneous report from a contactable physician (patient) via a sales representative. A patient of unspecified age and gender received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunisation. the patient medical history and concomitant medications were not reported. On an unknown date, the patient experienced should pain after vaccine from Pfizer. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
pt recvd 3 doses of Engerix-B titer checked 8 months p/3rd dose; titer result was neg;
Started feeling sick, feverish, night sweats, cough, heavy phlegm. Got worse & worse. Went to urgent care on 6/17. Immediately taken to ER and was admitted to hospital for 8 days. Discharged 6/25. Diagnosis was pneumonia. Almost died because my lungs were so full of infection.  I was perfectly prior to vaccine. No illnesses, lung problems, etc.  hadn?t even been to a dr for being ?sick? for a few  years.
booster took me out unlike 1 & 2; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (booster took me out unlike 1 & 2) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (booster took me out unlike 1 & 2) (seriousness criterion medically significant). At the time of the report, VACCINATION COMPLICATION (booster took me out unlike 1 & 2) outcome was unknown.            Relevant concomitant medications were not reported by the reporter. Treatment information was not provided by the reporter.  This is a spontaneous  case concerning a patient  of unknown age and gender, with no relevant medical history reported ,  who experienced the non serious  unexpected event   of  vaccination complication after receiving a third dose (booster) of Moderna COVID-19 vaccine. Time to onset is unknown. The benefit-risk relationship of Moderna COVID-19 vaccine is not affected by this report. Additional information has been requested.; Sender's Comments: This is a spontaneous  case concerning a patient  of unknown age and gender, with no relevant medical history reported ,  who experienced the non serious  unexpected event   of  vaccination complication after receiving a third dose (booster) of Moderna COVID-19 vaccine. Time to onset is unknown. The benefit-risk relationship of Moderna COVID-19 vaccine is not affected by this report. Additional information has been requested
Severe pain upon receipt of injection in left arm. Continued pain after three full days, painful to lift arm on fourth day. On first night of injection, had nausea chills arm pain and nerve sparking feeling throughout body
Pain in my right arm all the time since I've had the Moderna shot more than a month ago: in pain whenever I move the right are; try to carry something, reach for something behind me, etc.  Never had continual pain, sometimes sharp, in my arm before the shot. I do a good deal of computer work and now my arm is in constant pain as I work.
Severe pain in arm + fever 99 degrees receiving shot (L) for 48hrs -ice + Advil continued pain weeks 2, 3 - especially when lifting arm - Advil Week 4 - notified Pharmacy 11/10, spoke again 11/13 Limited range of motion lifting to front or side pain when lifting greater than 90 degrees using heat and Advil when needed
Severe headache with eye pain  arm of injection and so painful I could not hold a paperback book
fever; chills /get so chilly; colder last night; it burned like hell when the needle was removed from his arm; pain in his left deltoid muscle when he moves; This case was reported by a consumer via call center representative and described the occurrence of muscle pain in a 82-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Flu vaccine with an associated reaction of injection site pain (received a flu shot every year and would experience pain in his arm for 24 hours at the injection site but described the pain and experience as negligible and infrequent) and Vaccination with an associated reaction of feeling cold (in the army the patient would receive 5-6 vaccinations in one day and would get so chilly that he had to take a shower and the chills resolved). Concurrent medical conditions included drug allergy (from 55 years ago).   On 5th February 2020, the patient received the 1st dose of Shingrix (intramuscular). On 5th February 2020, less than a day after receiving Shingrix, the patient experienced fever, chills, coldness and injection site burning. In February 2020, the patient experienced muscle pain. On an unknown date, the outcome of the muscle pain, coldness and injection site burning were unknown and the outcome of the fever and chills were recovered/resolved.   It was unknown if the reporter considered the muscle pain, fever, chills, coldness and injection site burning to be related to Shingrix.  Additional details were provided as follows: The patient experienced pain in his left deltoid muscle when he moved.   The patient also had a fever and chills that have resolved and he was colder on the day of vaccination than he usually was.   The patient reported that for years he has been hot in the morning and cold at night.   He also reported that upon receiving the injection, it burned like hell when the needle was removed from his arm but the burning sensation has resolved.   The reporter consented to follow up.
I woke up in the morning with a fever. The fever was 100.4. I felt very achy. My joints really hurt, and I was tired. I stayed in bed most of the day and by 5pm I was feeling better.
Area where shot was given is red,warm, itchy, bumpy, and raised. It started a week after the shot was given.
Approximately 2 minutes after receiving the immunizations, the patient walked 3 feet and fell face first on the floor. She cried for about 5 seconds and became quiet. Her father picked her up but she was unable to stand. He cradled her in his arms - she opened her eyes briefly then became limp. Her skin appeared pale and her lips were cyanotic. I encouraged the father to seek medical attention for the patient and after verifying that she was a patient of the pediatric group in the same building, I accompanied the father (carrying patient) up to the doctor's office on the 3rd floor. She remained pale and her skin was moist, with cyanotic lips and unresponsive behavior in the elevator to the doctor's office. She had a small amount of blood on her lips as well. Upon arriving at the pediatric office and explaining what happened, I waited until the physician arrived before I returned to my clinic. The patient did not stop breathing during this incident.
Date of start of drug 01Jan2021;Date of start of drug 18Jan2021; Numbness and tingling of fingers on vaccine arm; Numbness and tingling of fingers on vaccine arm; bruise on back of arm away from injection site; flu like symptoms; This is a spontaneous report from a contactable pharmacist. A 25-year-old female patient received her second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on her left arm, via an unspecified route of administration on 18Jan2021 17:30 at a single dose for COVID-19 immunization. Medical history included anxiety. Concomitant medication included buspirone hydrochloride (BUSPAR), ethinylestradiol, levonorgestrel (CAMRESE), desvenlafaxine succinate (PRISTIQ) and trazodone. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on 01Jan2021 (first dose). It was reported that the patient had numbness and tingling of fingers on vaccine arm, bruise on back of arm away from injection site and flu like symptoms; all on 19Jan2021 at 05:00. No treatment was received for the events. The outcome of the events was recovered on unspecified dates.   Information about lot/batch number was requested.
Got both doses and still getting a few shingles/suspected Vaccination failure; Still getting a few shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix and Shingrix. On an unknown date, unknown after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient got the Shingrix vaccine about 2 years before the date of reporting and the booster 5 months later.  The patient still got few shingles on his/her ear and nose. The patient asked if getting another dose would help. This case was considered as suspected vaccination failure since the details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up would not possible as no contact details were available.
vaccine administered 1/19, red ring and pain and stiffness and heat on 1/28. redness is growing
Expiration date was 26FEB2023 and date the vial was initially stored in the refrigerator on 14MAR2023; No adverse event; had expired vaccine that was administered on March 15,2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (had expired vaccine that was administered on March 15,2023), PRODUCT STORAGE ERROR (Expiration date was 26FEB2023 and date the vial was initially stored in the refrigerator on 14MAR2023) and NO ADVERSE EVENT (No adverse event) in a 41-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 060B22A) for COVID-19 prophylaxis.     It was unknown if patient had ever been diagnosed with/ tested positive for COVID-19.     On 15-Mar-2023, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 15-Mar-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (had expired vaccine that was administered on March 15,2023). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Expiration date was 26FEB2023 and date the vial was initially stored in the refrigerator on 14MAR2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (had expired vaccine that was administered on March 15,2023), PRODUCT STORAGE ERROR (Expiration date was 26FEB2023 and date the vial was initially stored in the refrigerator on 14MAR2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (had expired vaccine that was administered on March 15,2023) and PRODUCT STORAGE ERROR (Expiration date was 26FEB2023 and date the vial was initially stored in the refrigerator on 14MAR2023).    Concomitant medication use information was not provided by reporter.  Vial size was reported as 10 dose vial.  Date the vial was initially stored in the refrigerator was reported as 14 March 2023. The vial did not undergo any temperature excursions.  Treatment Medication use information was not provided by reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-716065 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-716065:Master case